<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37073192</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>An Unusual Case of Blackout in a COVID-19 Patient: COVID-19 Brain Fog.</ArticleTitle><Pagination><StartPage>e36273</StartPage><MedlinePgn>e36273</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e36273</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.36273</ELocationID><Abstract><AbstractText>This case report highlights a unique case of brain fog in a COVID-19 patient suggesting COVID-19's neurotropic nature. COVID-19 is associated with a long-COVID syndrome that presents with cognitive decline and fatigue. Recent studies show the emergence of a novel syndrome known as post-acute COVID syndrome&#xa0;or long COVID,&#xa0;which constitutes a variety of symptoms that continue for&#xa0;four weeks following the onset of a COVID-19 diagnosis. Numerous post-COVID patients experience both&#xa0;short and long-lasting symptoms affecting several organs, including the brain, which includes being unconscious, bradyphrenia, or amnesia.&#xa0;This long COVID status comprises of "brain fog", which, coupled with neuro-cognitive effects, has a significant role in prolonging the recovery phase.&#xa0;The pathogenesis of brain fog is currently unknown.&#xa0;One of the leading causes might be the involvement of neuroinflammation due to mast cells stimulated by pathogenic and stress stimuli. This in turn, triggers the release of mediators that activate microglia, causing inflammation in the hypothalamus. Its ability to invade the nervous system through trans-neural or hematogenous mechanisms is possibly the chief cause behind the presenting symptoms.&#xa0;This case report highlights a unique case of brain fog in a COVID-19 patient suggesting COVID-19's neurotropic nature and how it may lead to neurologic complications such as meningitis, encephalitis, and Guillain-Barr&#xe9; syndrome.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Hassan et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Lareb</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Internal Medicine, Quaid-e-Azam Medical College, Bahawalpur, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahsan</LastName><ForeName>Zainab</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Internal Medicine, Combined Military Hospitals (CMH) Lahore Medical College and Institute of Dentistry, Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bint E Riaz</LastName><ForeName>Hunniya</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Internal Medicine, Combined Military Hospitals (CMH) Lahore Medical College and Institute of Dentistry, Lahore, PAK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">coronavirus disease 2019 (covid-19)</Keyword><Keyword MajorTopicYN="N">covid 19</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">guillain-barr&#xe9; syndrome (gbs)</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">neurological implications</Keyword><Keyword MajorTopicYN="N">sars-cov-2</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>1</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37073192</ArticleId><ArticleId IdType="pmc">PMC10105897</ArticleId><ArticleId IdType="doi">10.7759/cureus.36273</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO declares COVID-19 a pandemic. Cucinotta D, Vanelli M. https://pubmed.ncbi.nlm.nih.gov/32191675/ Acta Biomed. 2020;91:157&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. Petrilli CM, Jones SA, Yang J, et al.  https://pubmed.ncbi.nlm.nih.gov/32444366/ BMJ. 2020;369:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona virus: a review of COVID-19. Kumar D. https://www.ejmo.org/10.14744/ejmo.2020.51418/ Eurasian J Med Oncol . 2020;4:8&#x2013;25.</Citation></Reference><Reference><Citation>Characterization of the inflammatory response to severe COVID-19 illness. McElvaney OJ, McEvoy NL, McElvaney OF, et al.  https://pubmed.ncbi.nlm.nih.gov/32584597/ Am J Respir Crit Care Med. 2020;202:812&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke in young: an unusual presentation of COVID-19. Pawar T, Talwar D, Kumar S, Banode P, Takey P, Khanna S, Hulkoti V. https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1292471 Med Sci. 2021;25:1417&#x2013;1421.</Citation></Reference><Reference><Citation>Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19. Puccioni-Sohler M, Poton AR, Franklin M, da Silva SJ, Brindeiro R, Tanuri A. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534972/ Rev Soc Bras Med Trop. 2020;53:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534972</ArticleId><ArticleId IdType="pubmed">33027418</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Merrill JT, Erkan D, Winakur J, James JA. https://www.nature.com/articles/s41584-020-0474-5. Nat Rev Rheumatol. 2020;16:581&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391481</ArticleId><ArticleId IdType="pubmed">32733003</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and its implications for thrombosis and anticoagulation. Connors JM, Levy JH. https://pubmed.ncbi.nlm.nih.gov/32339221/ Blood. 2020;135:2033&#x2013;2040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>'Long COVID' syndrome. Taribagil P, Creer D, Tahir H. https://casereports.bmj.com/content/14/4/e241485 BMJ case reports. 2021;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057566</ArticleId><ArticleId IdType="pubmed">33875508</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurological associations of COVID-19. The. Ellul MA, Benjamin L, Singh B, et al.  https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30221-0/fulltext. Lancet Neurol. 2020;19:767&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Graham EL, Clark JR, Orban ZS, et al. Ann Clin Transl Neurol. 2021;8:1073&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Biofactors. 2021;47:232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>The extended autonomic system, dyshomeostasis, and COVID-19. Goldstein DS. Clin Auton Res. 2020;30:299&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7374073</ArticleId><ArticleId IdType="pubmed">32700055</ArticleId></ArticleIdList></Reference><Reference><Citation>Implications for neuromodulation therapy to control inflammation and related organ dysfunction in COVID-19. Fudim M, Qadri YJ, Ghadimi K, et al. J Cardiovasc Transl Res. 2020;13:894&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250255</ArticleId><ArticleId IdType="pubmed">32458400</ArticleId></ArticleIdList></Reference><Reference><Citation>Preventing cytokine storm syndrome in COVID-19 using &#x3b1;-1 adrenergic receptor antagonists. Konig MF, Powell M, Staedtke V, et al. J Clin Invest. 2020;130:3345&#x2013;3347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324164</ArticleId><ArticleId IdType="pubmed">32352407</ArticleId></ArticleIdList></Reference><Reference><Citation>Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Clin Med (Lond) 2021;21:0&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>A systematic review of neurological symptoms and complications of COVID-19. Chen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, Warnke C. J Neurol. 2021;268:392&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7370630</ArticleId><ArticleId IdType="pubmed">32691236</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of COVID-19 on the cerebrovascular system and the prevention of RBC lysis. Akhter N, Ahmad S, Alzahrani FA, et al. Eur Rev Med Pharmacol Sci. 2020;24:10267&#x2013;10278.</Citation><ArticleIdList><ArticleId IdType="pubmed">33090438</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillain-Barr&#xe9; syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B. J Peripher Nerv Syst. 2020;25:204&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273104</ArticleId><ArticleId IdType="pubmed">32388880</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurological manifestations and neuroimaging findings in patients with SARS-CoV2-a systematic review. Mohan N, Fayyaz MA, Del Rio C, et al. Egypt J Neurol Psychiatr Neurosurg. 2021;57:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8170868</ArticleId><ArticleId IdType="pubmed">34093004</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>